Related references
Note: Only part of the references are listed.Randomized Phase II Designs
Larry Rubinstein et al.
CLINICAL CANCER RESEARCH (2009)
Immunophenotypic Analysis of AIDS-Related Diffuse Large B-Cell Lymphoma and Clinical Implications in Patients From AIDS Malignancies Consortium Clinical Trials 010 and 034
Amy Chadburn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
被撤回的出版物: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium) (Retracted article. See vol. 65, pg. 861, 2012)
D. de Jong et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma:: results of a phase II trial
Josep-Maria Ribera et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-Cell lymphoma with analysis of germinal center and post-germinal center biomarkers
Wyndham H. Wilson et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
Georg Lenz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
HIV-associated lymphoma: the evidence for treating aggressively but with caution
Joseph A. Sparano
CURRENT OPINION IN ONCOLOGY (2007)
Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma
Francois Boue et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
Thomas M. Habermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy
Nicolas Mounier et al.
BLOOD (2006)
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:: a randomised controlled trial by the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2006)
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia
DA Thomas et al.
CANCER (2006)
Prognostic factors in HIV-related diffuse large-cell lymphoma: Before versus after highly active antiretroviral therapy
ST Lim et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010
LD Kaplan et al.
BLOOD (2005)
A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy
M Bower et al.
ANNALS OF INTERNAL MEDICINE (2005)
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials
M Spina et al.
BLOOD (2005)
Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV associated non-Hodgkin's lymphoma: An eastern cooperative oncology group trial (E1494)
JA Sparano et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Human immunodeficiency virus associated lymphoma
JA Sparano
CURRENT OPINION IN ONCOLOGY (2003)
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology
RF Little et al.
BLOOD (2003)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy
WH Wilson et al.
BLOOD (2002)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
HIV-associated non-Hodgkin lymphoma - Incidence, presentation, and prognosis
RF Little et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
